Susquehanna International Group
WST icon

Susquehanna International Group’s West Pharmaceutical WST Stock Holding History

Susquehanna International Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.99M Sell
7,926
-9,758
-55% -$2.43M ﹤0.01% 6192
2025
Q4 		$4.87M Buy
17,684
+9,345
+112% +$2.56M ﹤0.01% 4063
2025
Q3 		$2.19M Sell
8,339
-9,324
-53% -$2.27M ﹤0.01% 5584
2025
Q2 		$3.86M Buy
17,663
+10,632
+151% +$2.27M ﹤0.01% 4466
2025
Q1 		$1.57M Sell
7,031
-27,165
-79% -$7.49M ﹤0.01% 6094
2024
Q4 		$11.2M Buy
34,196
+15,002
+78% +$4.72M ﹤0.01% 2518
2024
Q3 		$5.76M Sell
19,194
-37,573
-66% -$11.5M ﹤0.01% 3370
2024
Q2 		$18.7M Buy
56,767
+38,502
+211% +$13.6M ﹤0.01% 1797
2024
Q1 		$7.23M Sell
18,265
-3,788
-17% -$1.4M ﹤0.01% 3078
2023
Q4 		$7.77M Sell
22,053
-51,021
-70% -$18.1M ﹤0.01% 3004
2023
Q3 		$27.4M Buy
73,074
+15,414
+27% +$5.96M 0.01% 1462
2023
Q2 		$22.1M Buy
57,660
+14,631
+34% +$5.23M ﹤0.01% 1634
2023
Q1 		$14.9M Buy
43,029
+15,319
+55% +$4.48M ﹤0.01% 1995
2022
Q4 		$6.52M Buy
27,710
+23,323
+532% +$5.53M ﹤0.01% 2844
2022
Q3 		$1.08M Sell
4,387
-39,460
-90% -$12M ﹤0.01% 6447
2022
Q2 		$13.3M Buy
43,847
+5,650
+15% +$1.84M ﹤0.01% 1858
2022
Q1 		$15.7M Sell
38,197
-16,676
-30% -$6.53M ﹤0.01% 1976
2021
Q4 		$25.7M Buy
54,873
+33,712
+159% +$14.5M ﹤0.01% 1603
2021
Q3 		$8.98M Sell
21,161
-32,522
-61% -$13.7M ﹤0.01% 3023
2021
Q2 		$19.3M Buy
53,683
+33,597
+167% +$11.1M ﹤0.01% 2074
2021
Q1 		$5.66M Sell
20,086
-4,915
-20% -$1.41M ﹤0.01% 3669
2020
Q4 		$7.08M Buy
25,001
+14,425
+136% +$4.05M ﹤0.01% 2926
2020
Q3 		$2.91M Buy
+10,576
New +$2.8M ﹤0.01% 3911
2020
Q2 		– Sell
-2,021
Closed -$397K – 11040
2020
Q1 		$308K Sell
2,021
-1,309
-39% -$201K ﹤0.01% 7921
2019
Q4 		$501K Sell
3,330
-10,161
-75% -$1.48M ﹤0.01% 6981
2019
Q3 		$1.91M Buy
13,491
+851
+7% +$117K ﹤0.01% 4286
2019
Q2 		$1.58M Buy
12,640
+1,473
+13% +$174K ﹤0.01% 4647
2019
Q1 		$1.23M Buy
+11,167
New +$1.16M ﹤0.01% 4611
2017
Q4 		– Sell
-5,127
Closed -$503K – 9994
2017
Q3 		$494K Buy
5,127
+1,712
+50% +$155K ﹤0.01% 6525
2017
Q2 		$323K Buy
+3,415
New +$314K ﹤0.01% 7458
2017
Q1 		– Sell
-16,580
Closed -$1.41M – 10103
2016
Q4 		$1.41M Hold
16,580
– – ﹤0.01% 4807
2016
Q3 		$1.24M Sell
16,580
-40,052
-71% -$3.18M ﹤0.01% 4403
2016
Q2 		$4.3M Buy
56,632
+32,410
+134% +$2.36M ﹤0.01% 2409
2016
Q1 		$1.68M Sell
24,222
-11,438
-32% -$688K ﹤0.01% 4105
2015
Q4 		$2.15M Buy
35,660
+15,015
+73% +$903K ﹤0.01% 3892
2015
Q3 		$1.12M Sell
20,645
-10,739
-34% -$626K ﹤0.01% 5505
2015
Q2 		$1.82M Sell
31,384
-11,390
-27% -$636K ﹤0.01% 4925
2015
Q1 		$2.58M Sell
42,774
-5,693
-12% -$303K ﹤0.01% 3822
2014
Q4 		$2.58M Buy
48,467
+20,186
+71% +$1.01M ﹤0.01% 3983
2014
Q3 		$1.27M Sell
28,281
-4,195
-13% -$178K ﹤0.01% 5467
2014
Q2 		$1.37M Buy
32,476
+26,819
+474% +$1.15M ﹤0.01% 5407
2014
Q1 		$249K Sell
5,657
-70,287
-93% -$3.31M ﹤0.01% 7895
2013
Q4 		$3.73M Buy
75,944
+18,748
+33% +$877K ﹤0.01% 3346
2013
Q3 		$2.35M Sell
57,196
-9,004
-14% -$343K ﹤0.01% 3842
2013
Q2 		$2.33M Buy
+66,200
New +$2.18M ﹤0.01% 3673

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group's WST Position: Q1 2026 in Review

Susquehanna International Group reduced its West Pharmaceutical (WST) stake by 55% in Q1 2026, selling an estimated $2.43M and leaving 7,926 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #6192.

Susquehanna International Group first reported a position in WST in Q2 2013 and has held it in 45 quarters since. The position peaked at $27.4M in Q3 2023. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Susquehanna International Group held 7,926 shares of West Pharmaceutical worth $1.99M as of Q1 2026.
  • Susquehanna International Group sold 9,758 West Pharmaceutical shares in Q1 2026, an estimated $2.43M.
  • West Pharmaceutical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6192 holding.
  • Susquehanna International Group first reported a position in West Pharmaceutical in Q2 2013 and has held it in 45 quarters since.
  • Susquehanna International Group's West Pharmaceutical position peaked at $27.4M in Q3 2023.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.